Science & Enterprise subscription

Follow us on Twitter

  • A new company developing treatments to relieve allergic reactions with reprogrammed antibodies began work and is ra… https://t.co/LFNVxych8d
    about 4 hours ago
  • New post on Science and Enterprise: New Allergy Biotech Launches, Raises $10M https://t.co/x5W0TwnCBu #Science #Business
    about 4 hours ago
  • Two companies and NIH are beginning a clinical trial of synthetic antibodies to both treat and prevent Covid-19 inf… https://t.co/LaUrUiRmhk
    about 23 hours ago
  • New post on Science and Enterprise: Trial Set for Covid-19 Antibodies in Long-Term Care https://t.co/tF0a7CDgGr #Science #Business
    about 23 hours ago
  • The numbers of vaccine candidates in development and clinical trials show modest but steady growth, now up to 157 a… https://t.co/AO2DxxTgF8
    about 1 day ago

Please share Science & Enterprise

Synthetic Protein Maker Raises $91.3M in Venture Funds

Elastapure bottle

A company creating animal-free designer proteins for skin care products is raising more than $91 million in its second venture funding round. . . . → Read More: Synthetic Protein Maker Raises $91.3M in Venture Funds

Covid-19 Vaccines, Therapies – 27 July 2020

Covid-19 vaccine and therapy tracker

This week’s chart shows since last Monday more new activity for therapies than vaccines, with 15 new Covid-19 therapies joining the array of treatments in development. . . . → Read More: Covid-19 Vaccines, Therapies – 27 July 2020

Synthetic Protein Designed to Boost Covid-19 Vaccines

Jason McLellan and Daniel Wrapp

Researchers in Texas designed a synthetic version of a protein found on Covid-19 viruses that can make it easier to produce more vaccines. . . . → Read More: Synthetic Protein Designed to Boost Covid-19 Vaccines

Advanced Solid Tumor Precision Meds. Trial Begins

Brain tumor graphic

A clinical trial is underway testing a treatment for advanced-stage cancers that blocks amino acids allowing nutrients to feed the growth of solid tumors. . . . → Read More: Advanced Solid Tumor Precision Meds. Trial Begins

Trial Testing Point-of-Care Covid-19 Diagnostic

A clinical trial in the U.K. is assessing a testing device to detect Covid-19 viruses in nasal swab samples that returns results in an hour. . . . → Read More: Trial Testing Point-of-Care Covid-19 Diagnostic

NIH Expands Covid-19 Test Technology Challenge

Covid-19 testing

National Institutes of Health is expanding its challenge competition to make tests for Covid-19 viruses more widely available and return results faster. . . . → Read More: NIH Expands Covid-19 Test Technology Challenge

Start-Up Developing Inside-Cell Delivery, Gains $28.5M

Vesicles

A new company spun-off from Harvard University is developing techniques for delivering advanced genetic and protein therapies directly inside cells. . . . → Read More: Start-Up Developing Inside-Cell Delivery, Gains $28.5M

Tough Surgical Adhesive Commercially Licensed

Gel adhesive

A bio-materials company is acquiring the rights to develop dental sutures and membranes from an adhesive gel developed in a university lab. . . . → Read More: Tough Surgical Adhesive Commercially Licensed

Gene Therapy Production Company Opens, Raises $40M

Adeno-associated virus

A new enterprise developing and manufacturing gene therapies, both its own and for others, is underway, raising $40 million in venture funds. . . . → Read More: Gene Therapy Production Company Opens, Raises $40M

High-Capacity Brain Signal Reader Demonstrated

Brain circuits illustration

A brain-computer interface device is shown to record the highest volume of brain signals from lab animals and sheep, according to its developers. . . . → Read More: High-Capacity Brain Signal Reader Demonstrated